In traditional Asian medicinal systems, preparations of the root and stem bark of
Magnolia species are widely used to treat anxiety and other nervous disturbances. The biphenyl-type neolignan honokiol together with its isomer magnolol are the main constituents of
Magnolia bark extracts. We have previously identified a nitrogen-containing honokiol derivative (3-acetylamino-
4&
prime;-
O-methylhonokiol,
AMH) as a high efficient modulator of GABA
A receptors. Here we further elucidate the structure-activity relation of a series of nitrogenated biphenyl-neolignan derivatives by analysing allosteric modulation and agonistic effects on 伪
1尾
2纬
2S GABA
A receptors. The strongest
IGABA enhancement was induced by compound
5 (3-
acetamido-
4&
prime;-ethoxy-3&
prime;,5-dipropylbiphenyl-2-ol,
Emax: 123.
4 ± 9.
4% of
IGABA-max) and
6 (5&
prime;-amino-2-ethoxy-3&
prime;,5-dipropylbiphenyl-
4&
prime;-ol,
Emax: 117.7 ± 13.5% of
IGABA-max). Compound
5 displayed, however, a significantly higher potency (EC
50 = 1.8 ± 1.1 渭M) than compound
6 (EC
50 = 20.
4 ±
4.3 渭M).
Honokiol, AMH and four of the derivatives induced significant inward currents in the absence of GABA. Strong partial agonists were honokiol (inducing 78 ± 6% of IGABA-max), AMH (63 ± 6%), 5′-amino-2-O-methylhonokiol (1) (59 ± 1%) and 2-methoxy-5′-nitro-3′,5-dipropylbiphenyl-4′-ol (3) (52 ± 1%). 3-N-Acetylamino-4′-ethoxy-3′,5-dipropyl-biphenyl-4′-ol (5) and 3-amino-4′-ethoxy-3′,5-dipropyl-biphenyl-4′-ol (7) were less efficacious but even more potent (5: EC50 = 6.9 ± 1.0 渭M; 7: EC50 = 33.2 ± 5.1 渭M) than the full agonist GABA.